CardioSource WorldNews
Patients are starting to demand transcatheter aortic valve replacement (TAVR), and CMS is expanding the criteria to allow more patients to qualify for it. Many cardiac programs that didn’t immediately pursue the TAVR program are beginning to ask themselves if they should. The question we often hear is: How critical is a TAVR program to ensuring that the organization’s structural heart, valve, and cardiology service line is competitive and comprehensive? This column offers steps and considerations cardiac service line leaders can use to assess their current situations and determine if a TAVR program is right for their organization.
